Joshua Berlin Email & Phone Number

Redwood City, Ca, Us

I lead corporate alliances and business development at BioCentury and also oversee our events and multimedia teams. I am responsible for building corporate relationships with biopharma executives, investors and key industry stakeholders, particularly in key growth areas including Asia and Europe. I have dedicated much of my career (15+ years) to building cross-border relationships between Asia and the West. In this capacity, I created and serve on the Organizing Committee of BioCentury’s China Healthcare Summit and East-West Biopharma Summit, organized in collaboration with BayHelix and McKinsey & Company. I am also a co-founder of the annual East-West Healthcare Reception, held in San Francisco during the week of the JP Morgan Healthcare Conference. In Europe, I serve on the Organizing Committee of BioCentury's BioEquity Europe, the industry's premier CEO and investor conference.For commentary on the biopharma industry, please visit my Twitter site @BioPharmaJosh - www.twitter.com/biopharmajosh.

I created and led the emerging markets group for Elsevier Business Intelligence (now part of Informa plc), including PharmAsia News and the PharmAsia Summit. In this role, I served as editorial, business development and strategy lead for Asia and emerging markets. I built and led a team of bilingual Asia-based editors that first developed and launched PharmAsia News in 2007-08. Our group provided business and regulatory intelligence to biopharma and medical device executives doing business in China, India, Japan, Korea and the Pacific Rim. Increasingly, we also provided insight on other emerging markets including Brazil and Russia.In this role, I also led efforts to build and support our network of industry KOLs and other stakeholders who provided guidance, connections and exclusive insights for customers. Due to our work, PharmAsia News became the fastest-growing product for EBI, prior to its acquisition by Informa in November 2013. I also led initiatives to increase business and editorial opportunities in Asia and emerging markets for a suite of leading biopharma products, including "The Pink Sheet" and IN VIVO.In addition, I helped launch and led the annual PharmAsia Summit, providing strategic direction and developing the program in collaboration with an organizing committee of top thought leaders. After two years in San Francisco, we hosted the Summit twice in Shanghai, in 2012-13, in partnership with the BayHelix Group, working also with a knowledge partner, first Monitor Group and then McKinsey & Co., to develop a conference report on new growth models for China.To capture new business and adapt to evolving opportunities and competition on the Web, I also helped to develop EBI's social media strategy. I oversaw the creation of business intelligence blogs and social media sites that leveraged subscription-based publications and search engine optimization to generate and qualify leads for subscriptions, advertising and sponsorship.

I served as executive editor of "The Pink Sheet" DAILY, managing a team of reporters and leading a strategic overhaul of the biopharma industry's top daily subscription e-newsletter. In particular, I helped to develop and lead our strategy for competing against free news sites on the web. As part of this initiative, I enhanced the depth of insight and analysis in our regulatory and business coverage; increased the amount of exclusive content in each issue; and provided direction and support for our sales and marketing team to ensure proper messaging and focus.

To take advantage of a major expansion in Medicare drug coverage, I helped develop the Medicare Drug Reimbursement Guide, an award-winning loose-leaf subscription manual and website providing in-depth analysis of Part B and D drug coverage for biopharma companies. As part of this project, I wrote a monthly 12-page newsletter on Medicare developments, worked with outside legal experts to develop and edit monthly updates to the manual, spearheaded our website strategy and execution, and helped to develop our marketing and sales strategy. In addition, I wrote and regularly contributed content to Medicare Drug Focus, a sister news e-publication.

London, Gb

As an E&Y manager, I helped provide non-financial compliance advisory services to U.S. and EU biotechnology and pharmaceutical companies. I served as chief of staff to a group developing non-financial tools to empower life sciences companies to benchmark compliance to global best practices promulgated by standards organizations, trade groups and related entities.As part of my responsibilities, I managed client relationships and deliverables, and spearheaded lead generation for our group.

I served as managing editor for a U.S. FDA enforcement and compliance manual for biopharma and medical device executives. In this position, I wrote a monthly newsletter focusing on FDA enforcement actions and policies, worked with our outside author to develop monthly updates and revisions to the compliance manual and coordinated with our editorial advisory board to develop additional offerings. In addition, I led the development of a subscription-based website that provided intelligence on FDA enforcement actions. I also assisted with direct marketing and lead generation efforts for our FDA group of products.

I served as a legal/regulatory researcher who focused on U.S. FDA regulations and policy that impacted biopharma, medical device and dietary supplement clients.

Washington, Dc, Us